Thursday, November 28, 2024
HomeTagsDystrophic epidermolysis bullosa

dystrophic epidermolysis bullosa

FDA Approves First Topical Gene Therapy for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa

The U.S. Food and Drug Administration approved Vyjuvek, a herpes-simplex virus type 1 (HSV-1) vector-based gene therapy, for the treatment of wounds in patients...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics